ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0507

Diagnostic performance of the lacrimal and salivary gland ultrasound in patients with primary Sjogren’s disease of recent onset versus sicca controls.

Rosa Elena Cervantes1, Carina Soto-Fajardo2, Fabian Carranza3, Gabriela Hernandez-Molina4, Narlly Ruíz Quintero5, Daniela Rojas Abarca6, Ana Mora7, Ada Rocío Morales Meza6, Carlos Montiel Castañeda8, Angela Maldonado Luna9, Fabiola Sánchez Zamudio6 and Carlos Pineda2, 1National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra"", Mexico City, Distrito Federal, Mexico, 2National Rehabilitation Institute " Luis Guillermo Ibarra Ibarra ", Mexico City, Mexico, 3National Rehabilitation Institute " Luis Guillermo Ibarra Ibarra ", Ciudad de México, Mexico, 4Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Federal District, Mexico, 5Instituto Nacional de Ciencias Medicas y Nutricion, México, city, Distrito Federal, Mexico, 6National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", Mexico, City, Distrito Federal, Mexico, 7National Rehabilitation Institute " Luis Guillermo Ibarra Ibarra ", Mexico, Mexico, 8National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", México, city, Distrito Federal, Mexico, 9Instituto Nacional de Ciencias Medicas y Nutricion, Mexico, City, Estado de México, Mexico

Meeting: ACR Convergence 2025

Keywords: Diagnostic criteria, Eye Disorders, Imaging, Sjögren's syndrome, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0506–0521) Sjögren’s Disease – Basic & Clinical Science Poster I: Etiology, Pathogenesis, Diagnosis

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Sjögren’s disease (SjD) is a chronic systemic autoimmune disease primarily affecting the exocrine glands. There is an increasing use of salivary gland ultrasound in SjD due to its good diagnostic yield and noninvasive, radiation-free, low-cost, and reproducible nature. Limited information exists on lacrimal gland ultrasound. The objective was to determine the usefulness of lacrimal and salivary gland ultrasound in diagnosing patients with primary SjD of recent onset compared to primary sicca syndrome.

Methods: We included primary SjD patients of recent onset (≤5 years) who fulfilled the 2016 ACR/EULAR criteria attending a tertiary reference center. We also included sicca controls matched by age(±5 years), sex, and disease duration (±5 years). An ophthalmologist evaluated keratoconjunctivitis sicca, including Schirmer test, OSS score, and Van Bijsterveld Score. We scored the ESSPRI and the Ocular Surface Disease Index [OSDI] questionnaire. We excluded both patients and controls with diabetes mellitus or with a body mass index ≥30.Ultrasound evaluation of the lacrimal and salivary glands (parotid and submandibular) was performed using a GE LOGIQe device with an 8-18 MHz linear probe. The OMERACT and Hocevar ultrasound scales were used for the salivary glands, and the scale reported by Kim et al. (1) for the lacrimal glands.

Results: We included 15 patients with primary SjD and 15 sicca controls. Patients and controls had similar symptoms, disease duration ( 60 months vs 40 months), and ESSPRI scores (6 points and 5 points). SjD patients had a higher degree of tear dysfunction than sicca controls (46.7% and 53.3% vs. 0% and 80% with moderate and mild damage, respectively; p=0.005). However, both groups had similar OSDI scores. Baseline characteristics are shown in Table 1.The OMERACT score had good diagnostic performance, with an AUC of 0.97 (95% CI: 0.89–1; p < 0.0001). The Hocevar scale, using two cut-off points of 14 and 17 points, had a good, adequate diagnostic performance, with an AUC of 0.93 (95% CI: 0.82-1; p < 0.0001) and 0.9 (95% CI: 0.77-1; p < 0.0001), respectively. Regarding the lacrimal gland, the presence of an intraglandular arterial branch, loss of homogeneity, hypoechoic areas, hyperechoic bands, and loss of glandular demarcation were features mainly observed in patients with SjD vs sicca controls (p < 0.0001 for each of them). Finally, we observed a strong correlation between the tear gland and Hocevar scores (rho = 0.83, p < 0.001).

Conclusion: Ultrasonography of both the lacrimal and salivary glands is a valuable diagnostic tool for identifying patients with primary SjD of recent onset from sicca controls.

Supporting image 1TABLE 1. Demographic and clinical characteristics of patients with SjD and SICCA syndrome.

Supporting image 2Figure 1. Examples of glandular ultrasounds performed on patients with SjD and sicca syndrome.


Disclosures: R. Cervantes: None; C. Soto-Fajardo: None; F. Carranza: None; G. Hernandez-Molina: None; N. Ruíz Quintero: None; D. Rojas Abarca: None; A. Mora: None; A. Morales Meza: None; C. Montiel Castañeda: None; A. Maldonado Luna: None; F. Sánchez Zamudio: None; C. Pineda: None.

To cite this abstract in AMA style:

Cervantes R, Soto-Fajardo C, Carranza F, Hernandez-Molina G, Ruíz Quintero N, Rojas Abarca D, Mora A, Morales Meza A, Montiel Castañeda C, Maldonado Luna A, Sánchez Zamudio F, Pineda C. Diagnostic performance of the lacrimal and salivary gland ultrasound in patients with primary Sjogren’s disease of recent onset versus sicca controls. [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/diagnostic-performance-of-the-lacrimal-and-salivary-gland-ultrasound-in-patients-with-primary-sjogrens-disease-of-recent-onset-versus-sicca-controls/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnostic-performance-of-the-lacrimal-and-salivary-gland-ultrasound-in-patients-with-primary-sjogrens-disease-of-recent-onset-versus-sicca-controls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology